Spyre Therapeutics Inc logo

Spyre Therapeutics Inc

SYRE
Healthcare|Biotechnology|USA
$97.74
-1.01 (-1.02%)
Tangible Book
$6.53

Upcoming Data Readouts (2)

Oct 2026
Est. completion
P2Rheumatoid Arthritis
A Study of SPY072 in Rheumatic Disease
NCT07148414n=285
Nov 2026
Est. completion
P1Healthy
A Study of SPY003-207 in Healthy Volunteers
NCT06873724n=59

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

Aug 2026
P1
A Study of SPY002-091 in Healthy Volunteers
NCT06672718

Recent Press Releases